1 completed, 1 withdrawn. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Withdrawn 1 |
Follow Respiratory: new trials by email Literature Review of Respiratory trials Research Report on Respiratory
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Therapeutic Equivalence and Safety of Fluticasone Furoate and Vilanterol Inhalation Powder 100 mcg/25 mcg and BREO ELLIPTA 100 mcg/25 mcg in Participants With Asthma Fluticasone furoate and vilanterol inhalation powder, Breo Ellipta, Placebo - Respiratory | Phase 3 | Withdrawn | Sandoz | 2026-04-21 | 2026-05-12 | |
| GPIAG and Leicester Asthma and Dysfunctional Breathing (GLAD) Study: a Randomised Controlled Study Physiotherapist - Asthma, Respiratory | Phase 3 | Completed | P Burns | 182 | 2003-10-01 | 2015-11-05 |
Asthma (1)
Bronchial Diseases (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Respiratory Hypersensitivity (1) · Respiratory Tract Diseases (1)
Physical Therapists (1) · fluticasone furoate (1)
Mike Thomas (1)